HEART-FID trial: Intravenous ferric carboxymaltose for heart failure with iron deficiency

Поделиться
HTML-код
  • Опубликовано: 13 окт 2023
  • Dr. Robert Mentz from Duke University Medical Center, discusses the HEART-FID Trial, where they investigated the efficacy and safety of intravenous ferric carboxymaltose for HFrEF.
    Learn more at cardiology-update.com
    #heartfailure #HFrEF #irondeficiency #esccongress #cardiologist #cardiology #cardiologyupdate

Комментарии •